Klearman Micki 4
4 · Kezar Life Sciences, Inc. · Filed Jun 3, 2021
Insider Transaction Report
Form 4
Klearman Micki
Director
Transactions
- Award
Stock Option (right to buy)
2021-06-01+52,000→ 52,000 totalExercise: $5.94Exp: 2031-05-31→ Common Stock (52,000 underlying)
Footnotes (1)
- [F1]One thirty-sixth (1/36th) of the shares shall vest on a monthly basis following the vesting commencement date of June 1, 2021, subject to the Reporting Person continuing to provide service through each such date.